caretech presentation team/media/files/c/caretech-uk/... · 2019. 6. 24. · caretech presentation...
TRANSCRIPT
CareTech Presentation Team
2
Farouq Sheikh Chairman
John Ivers Group Chief Operating Officer
Gareth Dufton Interim Group Finance Director
Agenda
3
Overview
Operational review
Financial review
Summary and outlook
Q&A
Unique access to the Social Care Market
4
What we do?
CareTech is a leading national provider of care services for children and adults with complex needs
We are the largest provider of care and education services to children in the UK
We operate in a c£15bn p.a. UK social care sector with high growth segment and favourable demographics with increased outsourcing of care
How do we do it?
We provide a range of care services, from residential care to supported living and education
Person centred planning, putting the service user first to deliver positive outcomes
What makes us unique?
We have highly motivated and empowered staff who combine care, property and finance expertise
CareTech’s innovative Care Pathways deliver positive outcomes for our service users and value for commissioners
Proven track record
5
CareTech have 25 years of experience in the care sector and 13 years on the public markets
Grown from a single home to 550 facilities and 10,000 staff supporting 4,500 service users
Building on our Care Pathways, we have expanded from learning disabilities services to encompass services across mental health, education, children’s residential care and therapeutic fostering
We are a trusted partner for local authorities with a proven track record of delivering the highest standards of care and governance
Unique platform with strong commitment to workforce engagement
Underlying EBITDA and EPS has grown by CAGR of 26% and 20% respectively since IPO
At IPO
• UK market size of £2.1bn• Capacity of 435• CareTech market share of less than 1%• One focused operating division – residential and day
care services for adults with learning disabilities
6
0
20
40
60
80
100
120
140
160
180
200
20
05
A
20
06
A
20
07
A
20
08
A
20
09
A
20
10
A
20
11
A
20
12
A
20
13
A
20
14
A
20
15
A
20
16
A
20
17
A
20
18
A
Revenue CAGR 18% A
0
5
10
15
20
25
30
35
40
45
50
200
5 A
200
6 A
200
7 A
200
8 A
200
9 A
201
0 A
201
1 A
201
2 A
201
3 A
201
4 A
201
5 A
201
6 A
201
7 A
201
8 A
EBITDA CAGR 26% A
0
5
10
15
20
25
30
35
40
200
5 A
200
6 A
200
7 A
200
8 A
200
9 A
201
0 A
201
1 A
201
2 A
201
3 A
201
4 A
201
5 A
201
6 A
201
7 A
201
8 A
EPS CAGR 20% A
Our journey so far…
Today
• UK Market size of £14.8bn per annum• Capacity of 5,072• CareTech market share of between 3% - 8%• Three specialist operating divisions:
Adult services: incorporating adult learning disability, mental health and acquired brain injuryChildren services: incorporating young people residential services and learning servicesFoster care: fostering services
Highlights
7
Financial
Revenue increased by 120% to £192.5m (2018: £87.6m)
Underlying EBITDA increased by 71% to £33.3m (2018: £19.5m)
Underlying profit before tax increase by 50% to £20.7m (2018: £13.8m)
Independent property valuation of £774m following Cambian acquisition
Integration of Cambian and synergy delivery well underway
Dividend increased by 7% to 3.75p (2018: 3.5p)
Operational
Completion of transformational acquisition of Cambian in October 2018 for £278.5m
Unconditional regulatory clearance from Competition and Markets Authority in February 2019
Maintained occupancy numbers and growth initiatives
CQC and OFSTED ratings continue to be ahead of sector averages
Staff retention initiatives proving successful with retention rates ahead of sector average
Acquisition of the Cambian Group
8
CareTech acquired Cambian Group plc in October 2018 for £278.5m (net of cash)
Financial benefits
Competitive price for a transformational acquisition
Purchase price part paid in shares, as we continue to build our vision
Opportunities for EBITDA margin enhancement and synergies in non-operational areas
Trading performance considerably improved since last reported results and synergies on track
Operational benefits
Greater diversification of service offering
Complementary geographical coverage, providing a true nationwide integrated care pathway
Highly skilled combined management team
Further growth and in-fill opportunities from enlarged group and enhanced care pathways
Management commitment
Founders and management committed a further c£4.75m in shares
Divisional breakdown
9Extraordinary days every day
Operational ReviewJohn Ivers, Group Chief Operating Officer
Favourable Demographics and Growth in Outsourcing Continues in our Markets
Increased public outsourcing of care
Key Drivers
Fragmented sector with room for consolidation
Opportunity to improve outcomes of current interventions
Focus on early intervention and preventing bed blocking NHS. Community based service approach.
Increasing numbers of Looked After Children and Adults
Increasing prevalence of learning disabilities, mental health and special education needs
Children andYoung People
£3.7bn(1) £1.
Sector Growth (%)
UK Social Care Market Size
£12.6bn(1)<5%
33%
<8%
60%
<3%
75%
£3.7bn(1) £1.6bn(1) £9.5bn(1)
Enlarged CareTechGroup Addressable Market Share
Independent sector Penetration
AdultsFostering
5.5%5.2%
(1) Laing and Buisson
Social Care Sector in UK
5.7%
10
Operational Update
‘More of the Same’ approach
- Growth underpinned by established solid operational foundations and platforms
- Business driver KPI’s on people, quality and bed-fills show sustained progress.
- Focus maintained on:
- Core organics/reconfigurations/targeted bolt-ons/Geographic and Care Pathway Extensions.
- CQC and OFSTED ratings continue to be ahead of sector averages.
‘Integration and Alignment’ approach
- Integration well underway
- Operational Team aligned and focused
- Progress on plan and towards CareTech Key Metrics.
- CareTech reporting and management review approach embedded
- Shared services and best practice approach across the Care Pathway.
11
Capacity 1,934 1,167 1,971
Sites280 residential sites
47 educational facilities11 locations 203 sites
Regulator Ratings
89% good/outstanding CareTech77% Cambian 100% good rated with Ofsted 94% good/outstanding CQC rated
Foster Care Adult ServicesChildren Services
Operating segments
12
Areas of specialism
Learning disability
Mental Health Issues
Autism Spectrum Conditions
Complex social, emotional and
behavioural difficulties
Young people in crisis
Education and Therapy
Foster Placements for Children
and Young People with
challenging and complex
behaviours
Family placements for Children
and Young People with disabilities
Learning disabilities
Mental Health
Autism and Asperger’s
Physical disabilities
Sensory Impairment
Dual Diagnosis
Brain Injury Rehabilitation
Our Care Pathways
Children and Young People Services
Special Education
Needs, SEMH and LD
Therapy and
Residential Services
Short Breaks/Respite
Leaving Care 16+
Fostering Care
Learning Services
Service Users:
- Apprenticeships
- Employability programmes
Workforce:
- Leadership and Career
Development
- Training and Support
Community Based Adult Services
Learning Disability
Mental Health
Physical Disability
Dementia/Aspergers
Respite Care
Support and
Rehabilitation
Specialist Services
Acquired Brain Injury Rehabilitation Campus and
Stepdown Services
Specialist Mental Health Recovery
Hospital and Stepdown Services
Complex Home Healthcare
Palliative Care
Our Approach Delivering
Over 10,000 expert trained and quality focused staff provide care through over 500 sites
Tailored to individual service user and family requirements
High Quality
Outcome focused
Promoting independence and choice
Excellent Value
13
14
Enlarged Group – Operational Imperatives
Financial PerformanceCareTech Revenue +12% margin 20.6%
Cambian pre-synergy margin 13.2%vs 10.9% LY18(HI 2018/19)
• Winning Formula• Leveraging Operational Expertise across Group• Common Management Focus/KPI driven
Our PeopleAnnualised Staff retention
77% CareTech71% Cambian
87 Leadership Programme 202 staff SAYE scheme
427 Apprenticeship Diploma LearnersCare Awards
High Quality PerformanceGood/Outstanding Ratings
94% Adults89% CareTech Children’s
77% Cambian
High Occupancy Levels87% blended/93% mature CareTech
75% overall Cambian
15
Growing and Developing our Business
Core Services
CareTech +39 beds (HI 2018/19)
Reconfigurations
CareTech +13 beds (HI 2018/19)
Geographic and Service Infill Projects
CareTech +6 additional beds(HI 2018/19)
Expansion underway North West/South West/ South East/ Scotland
Financial PerformanceCareTech Revenue +12% margin 20.6%
Cambian pre-synergy margin 13.2%vs 10.9% LY18(HI 2018/19)
Additional opportunities
Bolt-onsGrowth within enlarged group
International opportunities
Children’s and Young People’s Residential and Educational Services
16
Operational Snapshot Key Strategic Priorities
Group Capacity 1,934CareTech (356 Places)Cambian (1,578 places)
Occupancy Blended84% CareTech75% Cambian
Quality Ratings Ofsted89% Good/Outstanding (CareTech)77% Good/Outstanding (Cambian)
Services280 Residential sites47 Educational Facilities
• Service Specialisation Focus
- complex care - sexual trauma- CAMHS
• Care/Education/Therapy Approach
• Maximise occupancy of current capacity
• Fee and Referral Management
• Recruit and retain to service core and emerging services
• Partnership working with LA
• Managing positive outcomes and transitions across Pathways
• Maintain ‘Best in Class’ quality and reputation for service delivery
5,239Employees
17
Children’s Services Recent Projects
Culcheth House – Opened January 20195 bedded home. Located in Culcheth near Warrington. Home at full capacity as of April 2019.
Nanny Brook – Due to open in July 2019Located in Oakenclough, near Preston.5 bedded home in a very rural location
The Vicarage – Opened November 2018.Based in Gloucester, is a 5 bed converted Chapel providing Supported Accommodation for Young People aged 16 -18 years.Currently home to four Young People.
Foster Care
18
652 Foster Parents160 CareTech492 Cambian
1,167 Places301 CareTech866 Cambian
230Employees
11 locations3 CareTech8 Cambian
Quality Ratings Ofsted100% good rated services
Embed Therapeutic Fostering approach
Continued focus on carer pipeline and referrals
Managing fill rate
Family assessment and support centre as a value added service.
Operational Snapshot Key Strategic Priorities
Adult Services
203 SitesFreehold facilities
1,971Bed / Places
89%Blended Occupancy
3,661Employees
Quality Ratings CQC94% Good/outstanding
Specialist Community social care services across the UK
Established 25 years ago as the initial CareTech service and brand
Extended service offering learning disability/mental health/physical disabilities and neuro rehabilitation.
Geographic and specialist service pathway infill.
Reconfiguring services to meet changing needs and demand- Step down and rehabilitation- Communal supported living promoting independence and choice
- Apartments and self-contained flats
Developing new projects to meet growing needs
Operational Snapshot Key Strategic Priorities
19
20
Adult Services Recent Projects
Victoria Lodge is a six-bed community based acquired brain injury residentialservice (including 1 flat) in Bognor Regis for adults. Located in the heart of thecommunity Victoria Lodge allows easy access via public transport to local educationand vocational opportunities. Opened on 19 March 2019.
Uplands completed £1m refurbishment of Uplands Hospital, Farnham, resulting in24 operational beds through a recovery model for those with Mental Healthconditions. Updated facilities include clinical treatment rooms, soothing sensoryrooms and a therapy room. Opened on 26 March 2019.
Brisbane Road is located in Ilford, Essex. Following the success in 2015 of creating5 one bedroom self contained flats, we have now completed the redevelopment ofthe ‘Activities/Meeting room’ at the rear of Brisbane Road. The redevelopment thatopened in May 2019 has provided two more self-contained one bedroom flats.
21
Operational Way Forward
Underway with:
Aligned CareTech and Cambian team (Approach/Focus/Review)
Shared best practice approach
Our People (recruit/retain/develop/recognise)
Continued High Quality Performance (Line of Sight)
Reconfiguring Assets/Projects for Geographic and Service infills
Integrated Support and Back Office (Shared Services)
Joint collaboration opportunities across Care Pathways
Combined Business Development and fee management approach
Divisional breakdown
22Extraordinary days every day
Financial Results for the 6 months to March 2019Gareth Dufton, Interim Group Finance Director
Extraordinary days every day
23
Revenue increased by 120% to £192.5m
Underlying EBITDA increased by 71% to £33.3m
Underlying EPS increased by 6.5% to 15.82p
Strong operating cash conversion c85%* (excludes Cambian pre-acquisition period)
Integration underway and synergies delivered
Independent property valuation on acquisition of £774m
Bank facilities in place until 2022/2023 including an undrawn £25m revolving credit facility
Ground rent transaction completed, raising £31m proceeds at 2.85% NIY
Net debt of £293.0m
Interim dividend increased by 7% to 3.75p
Financial Highlights
for the six months ended 31 March 2019
24
Financial Highlights
Group CareTech Cambian
Revenue £192.5m £98.2m £94.2m
Underlying EBITDA £33.3m £20.2m £13.1m
EBITDA margin 17.3% 20.6% 13.9%
EBITDA margin (pre-synergies) 13.2%
Operating cash conversion 85% 97% 100%*
Property valuation £774m £424m £350m
*including 18 days pre-acquisition
Cambian results for post acquisition period from 19 October 2018
25
Operating Segmentsfor the six months ended 31 March 2019
Six months ended Six months ended
2019 2019 2018 2018
Revenue EBITDA Margin Revenue EBITDA Margin
£m £m £m £m
Adults Services
CareTech 62.1 15.0 24% 58.2 15.3 26%
Cambian - - - -
62.1 15.0 58.2 15.3
Children's Services
CareTech 32.1 8.4 26% 25.2 7.0 27%
Cambian 78.7 18.1 23% - -
110.8 26.5 25.2 7.0
Foster Care
CareTech 4.0 0.8 20% 4.0 1.0 25%
Cambian 15.5 2.8 18% - -
19.5 3.6 4.0 1.0
Unallocated costs (11.7) - (3.8)
Total 192.5 33.3 17% 87.5 19.5 22%
Non underlying items
26
Financials
Six months ended Six months ended
31-Mar-19 31-Mar-18
unaudited unaudited
£000 £000
Acquisition expenses 10,318 -
Integration and restructuring costs 2,354 1,111
Profit arising from the ground rent transaction (4,565) -
Charitable donations 390 -
Termination of onerous leases - 727
Amortisation of intangible assets 4,922 3,558
Non underlying items 13,419 5,396
Fair value movements relating to derivative financial instruments (153) (468)
Charges relating to derivative financial instruments 86 341
IAS 17 lease imputed interest 112 112
Finance fees extinguished 396 -
Included in financial expenses 441 -15
Tax effect:
Current tax 101 (349)
Deferred tax (3,363) (316)
Included in taxation (3,262) (665)
Total non underlying items 10,598 4,716
27
Cambian - Integration and Synergies
Margin improvement plan being delivered improvement to 13.2% (pre synergies) from 10.9% (June 2018)
Systems & back office integration under way
IT costs streamlined and a new IT strategy in place
On track to deliver synergies of £3m PBT – FY2019 CEO, CFO and all non-executive board members have left the group Number of senior management team savings Exercised break clause on lease of Cambian head office
Visibility of £5m PBT synergies by FY2020
Operational benefits not factored into any integration analysis
Cash flow and balance sheet KPI’s as at 31 March 2019
28
Cash Flow Balance Sheet and KPI’s
£m £m
EBITDA 33.3 Property Valuation c 19 September 2019 774.1
Movement in working capital* (5.0) Tangible fixed assets - net book value 600.5
Capital expenditure (16.7) Net debt (293.0)
Acquisition of Cambian (net of cash acquired) (160.5) Net assets 328.4
Proceeds from ground rent transaction 31.0 Cash & undrawn facilities 51.7
Non underlying and acquisition costs (17.6)
Tax interest and dividends (10.3) Covenants
Movement in net debt (146.0) EBITDA: Interest 5.7:1
Opening net debt (147.0) Net debt: EBITDA 3.9:1
Closing net debt (293.0) Loan: Value 42%
* excludes the pre-acquisition period
IFRS16 - Leases
To be adopted for FY 30 September 2020
Adopting “modified retrospective” transitional approach
Mainly property leases effected. Short term leases (<12 months) and low value (c£4k) excluded
IFRS 16 will not have any impact on:
Bank covenants
the underlying commercial terms of each lease
the commercial performance of the Group
cash flow generated in the year
Immaterial impact on EPS
29
Divisional breakdown
30
Summary and OutlookFarouq Sheikh, Chairman
Extraordinary days every day
31
Revenue £23m
EBITDA £2.4m
EPS 4.1p
Market size £2.1bn
Market Share
1%
Revenue £123.3m
EBITDA £30.7m
EPS 31.02p
Market size £9.7bn
Market Share
<2%
Revenue £185.7m
EBITDA £43.9m
EPS 35.07p
Market size £12.6bn
Market Share
3%
Revenue £192.5m
EBITDA £33.3m
EPS 15.82p
Market size £14.8bn
Market Share
3% - 8%
Underlying market factors remain positive Regulatory burden increasing Shortage of specialist beds
Continued focus on the integration of Cambian, delivering synergy targets & improving margins Improved staff retention & quality ratings
will lead to increased occupancy levels
Consolidation in the sector
Harnessing technology Use to assist with care provision (Tele care) Validating & tracking outcomes using
technology Diagnostic tools Monitoring and support
International Development Arab Health 2018 Exploring related opportunities
Direction of Travel
Half Year Actual 2019
Enlarged GroupAdded value creationand synergies: Scale benefit, services and coverage extended. • £6m synergies by FY2021 • Improving Cambian
performance • Market share 6%+
IPO 2005 Actual 2018Placing 2015
Outlook
Strong start to the year
Trading in line with current market expectations
Cambian integration well on track
CareTech is a profitable, cash generative and asset backed business with an attractive yield
Experienced and strengthened management team through the acquisition of Cambian whose interests are aligned with shareholders
Highly fragmented market with growth opportunities through organic and acquisition
A business model that is flexible, scalable and well positioned for growth
32
SummarySummary
Extraordinary days every day 33
Q&A
Extraordinary days every day
Disclaimer
This presentation has been prepared by CareTech Holdings PLC (“CareTech” or the “Company”) and the information contained herein is restricted and is not intended for distribution to, or use by any person or entity in any jurisdiction
or country where such distribution or use would be contrary to local law or regulation. In particular, the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States,
Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction in which such release, publication or distribution would be unlawful.
The presentation and the information contained herein is for information purposes only and shall not constitute an offer to sell or otherwise issue or the solicitation of an offer to buy, subscribe for or otherwise acquire securities in any
jurisdiction in which any such offer or solicitation would be unlawful. This presentation and the information herein does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to purchase, acquire or
subscribe for any securities in the United States, Canada, Australia, Japan or the Republic of South Africa and may not be viewed by persons in the United States (within the meaning of Regulation S under the US Securities Act of 1933, as
amended (the “Securities Act”)). Securities in the Company may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and
the securities law of any relevant state or other jurisdiction of the United States.
Recipients in jurisdictions outside the United Kingdom should inform themselves about and observe any applicable legal or regulatory requirements in relation to the distribution or possession of these presentation slides to or in that
jurisdiction. In this respect, neither CareTech nor any of its connected persons accepts any liability to any person in relation to the distribution or possession of these presentation slides to or in any such jurisdiction.
This presentation is strictly confidential and is being provided to you solely for your information and may not be reproduced in any form or further distributed to any person or published in whole or in part, for any purpose; any failure to
comply with this restriction may constitute a violation of applicable securities laws.
This presentation has not been (i) produced as a result of a process which was designed to ensure that it satisfies the standards, of accuracy, disclosure or completeness required of a prospectus, or listing particulars or other disclosure
document to be published in connection with an application for shares or other securities to be admitted to listing or dealing or trading on a regulated market or a recognised investment exchange (as defined in the Financial Services and
Markets Act 2000 (“FSMA”)) (ii) approved for the purposes of section 21 of FSMA by, a person authorised under FSMA or (iii) subjected to the due diligence investigations, verifications and other procedures commonly carried out or
applied in relation to the publication of a prospectus, listing particulars or other disclosure document on such an application, nor does it contain all information that would be required if it were a prospectus for the purposes of Directive
2003/71/EC. Accordingly, this presentation does not purport to be all-inclusive.
In making this presentation available, CareTech makes no recommendation to buy, sell or otherwise deal in shares in CareTech and its subsidiaries (the “Group”) or in any other securities or investments whatsoever, and you should
neither rely nor act upon, directly or indirectly, any of the information contained in these presentation slides in respect of any such investment activity. Past performance is no guide to future performance. If you are considering engaging
in investment activity, you should seek appropriate independent financial advice and make your own assessment.
This presentation (and any subsequent discussions arising thereon) may contain certain statements, statistics and projections that are or may be forward-looking. The accuracy and completeness of all such statements, including, without
limitation, statements regarding the future financial position, strategy, projected costs, plans and objectives for the management of future operations of the Group are not warranted or guaranteed. By their nature, forward-looking
statements involve risk and uncertainty because they relate to events and depend on circumstances that may occur in the future. Although CareTech believes that the expectations reflected in such statements are reasonable, no
assurance can be given that such expectations will prove to be correct. There are a number of factors, many of which are beyond the control of the Group, which could cause actual results and developments to differ materially from
those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors such as: future revenues being lower than expected; increasing competitive pressures in the industry; and/or general
economic conditions or conditions affecting the relevant industry, both domestically and internationally, being less favourable than expected. We do not intend to publicly update or revise these projections or other forward-looking
statements to reflect events or circumstances after the date hereof, and we do not assume any responsibility for doing so. By accepting these presentation slides, you agree to be bound by the above conditions and limitations
34